Our News on Newswise

Newswise: 656dcb47ad91b_ViHCoverNo-ToC2019-03.jpg

Global Experts Highlight Concerns With Implementation of IRA-Mandated Medicare Drug Price Negotiation Program

Value in Health announced the publication of 2 new commentaries by leading HEOR experts, both of which raise important questions as the Centers for Medicare & Medicaid Services move forward to implement the Inflation Reduction Act’s Medicare Drug...
5-Dec-2023 4:05 AM EST Add to Favorites

Newswise: 6540106009371_ViHCoverNo-ToC2019-03.jpg

Medicare Could Save an Additional $10 Billion Annually Across 10 Drugs by Using a Therapeutic Reference Pricing Approach in Upcoming Price Negotiations

Value in Health announced the publication of a study showing that United States Medicare could save up to an additional $5-$10 billion dollars annually across 10 drugs if it negotiated prices using a therapeutic reference pricing approach rather...
7-Nov-2023 4:05 AM EST Add to Favorites

Newswise: 654003952fdef_ViHCoverNo-ToC2019-03.jpg

Global Medical Device Panel Finds Little Evidence Linking Health Technology Assessment Processes to Medical Device Purchasing Decisions

Value in Health, the official journal of ISPOR, announced the publication of a systematic literature review showing that there is sparce evidence in the health research literature to link health technology assessment processes and outcomes with...
6-Nov-2023 4:05 AM EST Add to Favorites

Newswise: 6511bd1db1f5a_HEOR-Awards-2023Image150x200.jpg

ISPOR Announces 2023 Health Economics and Outcomes Research Award Honorees

ISPOR—The Professional Society for Health Economics and Outcomes Research announced the recipients of its 2023 Health Economics and Outcomes Research (HEOR) Scientific and Leadership Awards.
3-Oct-2023 4:05 AM EDT Add to Favorites

Newswise: 650c542a98bab_000Europe-ISPOR2023150x200.jpg

ISPOR Europe 2023 Plenaries and Speakers Announced

ISPOR—The Professional Society for Health Economics and Outcomes Research announced the plenary sessions and speakers for ISPOR Europe 2023. The conference is scheduled for 12-15 November in Copenhagen, Denmark with the theme, “Health Economics...
25-Sep-2023 4:05 AM EDT Add to Favorites

Newswise: 64f091bf0e904_ViHCoverNo-ToC2019-03.jpg

Proposed Drug Pricing Policy Would Save Medicare Between $1 Billion and $2.1 Billion Annually

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the publication of a report that identifies expensive Medicare Part B drugs with low added therapeutic benefit and models...
5-Sep-2023 4:05 AM EDT Add to Favorites

Newswise: 64e5f701ed047_Laura-Pizzi8x10Crop.jpg

ISPOR Announces New Chief Science Officer

ISPOR—The Professional Society for Health Economics and Outcomes Research announced today that Laura Pizzi, PharmD, MPH will be assuming the role of Chief Science Officer at the Society. ISPOR’s previous Chief Science Officer, Richard J. Willke,...
28-Aug-2023 4:05 AM EDT Add to Favorites

Newswise: 64c3e4cd8a060_ViHCoverNo-ToC2019-03.jpg

Global Multistakeholder Panel Provides First-of-its-Kind Guidance on Assessing the Value of Biosimilar Drugs

ISPOR—The Professional Society for Health Economics and Outcomes Research published a new ISPOR Report that provides an overview of gaps and challenges in the value assessment of biosimilars and identifying potential approaches to address them....
15-Aug-2023 4:05 AM EDT Add to Favorites


See All News

Our Experts on Newswise

Our experts are coming soon...

Our YouTube Videos

About

ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.

ISPOR’s community of 14,000 individual and chapter members from more than 100 countries includes a wide variety of healthcare stakeholders, including researchers and academicians, assessors and regulators, payers and policy makers, the life sciences industry, healthcare providers, and patient engagement organizations. The Society’s leadership has served as an unbiased resource and catalyst for innovation in the field for more than 25 years.

Experts

Contacts

Margaret Fontana
Associate Director Marketing Communications

MFontana@ispor.org

Betsy Lane
Chief Marketing and Communications Officer

blane@ispor.org

609-586-4981 x 112

Emily Sinkiewicz
Senior Manager, Marketing and Commumications

esinkiewicz@ispor.org

609-586-4981 x114

Twitter

Instagram

Instagram feed not yet configured. Click "Edit Instagram Feed" to enter your Instagram details.
close
0.25173